A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds.
1. It is proposed that part of a neurotoxic dose of di-isopropyl phosphorofluoridate will be covalently bound in vivo to a specific component in the brain and spinal cord as the initial biochemical event in the genesis of the lesion. 2. A test system in vitro was devised that removes many di-isopropyl phosphorofluoridate-binding sites and indicates that the specific component may be a protein present in brain at a concentration comparable with that of the cholinesterases. 3. The site was found to be present and capable of binding di-isopropyl phosphorofluoridate in vitro in brain samples taken from either normal hens or those dosed with organophosphorus esterase inhibitors that are not neurotoxic. 4. Very little of the specific binding activity was found in brain samples from hens pre-dosed with a variety of neurotoxic organophosphorus compounds. 5. A solubilized preparation of the active brain component was obtained, suitable for further purification and study.
D000818:Animals; D001923:Brain Chemistry; D001927:Brain Diseases / Q000139:chemically induced; D002645:Chickens; D002802:Cholinesterases / Q000032:analysis; D004950:Esterases / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000633:toxicity*; D009419:Nerve Tissue Proteins / Q000032:analysis; D010710:Phosphates / Q000494:pharmacology; D011955:Receptors, Drug; D013118:Spinal Cord Diseases / Q000139:chemically induced
D009419:Nerve Tissue Proteins; D010710:Phosphates; D011955:Receptors, Drug; D007531:Isoflurophate; D004950:Esterases; D002802:Cholinesterases